Datum Orthobiologics to Develop New Biomaterials

Datum Orthobiologics has been founded and is raising funds to develop bio-programmable biomaterials with musculoskeletal applications. The company will first focus on bone grafts for use in fracture healing and spinal fusion.

Datum Orthobiologics benefits from patented GLYMATRIX® technology, which is based on 25+ years of R&D and...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us